|Salary:||£40,223 to £44,722 per annum (pro-rata), including London allowance (grade 4).|
|Placed On:||14th September 2023|
|Closes:||12th October 2023|
About the Role
A 3-year MRC-funded PDRA position is available to study a novel metabolic pathway that we recently identified (Altea-Manzano et al. Mol Cell 2022) as a potential therapeutic target for highly aggressive breast cancer. Techniques will include molecular biology, metabolic mass spectrometry and in vivo studies, including stable isotope tracing.
The post requires a dedicated PDRA with a PhD in a relevant subject. The study requires substantial skills in cell and molecular biology and in vivo skills are an advantage. First author publications will provide evidence that you have experience in completing studies through to the final manuscript.
About the School/Department/Institute/Project
The Barts Cancer Institute (BCI) is a Cancer Research UK Centre of Excellence whose work aims to transform the lives of those with and at risk of cancer through innovative research in the laboratory, in patients and in populations. It is one of six institutes within The Faculty of Medicine and Dentistry (FMD) BCI is internationally renowned in many areas of cancer research and it combines ground-breaking basic research with the expertise of clinicians and clinician scientists from the Centre for Experimental Cancer Medicine and the Barts NHS Trust to achieve improvements in cancer patient care. BCI is also a partner in the CRUK City of London Major Centre (together with UCL, Kings and the Francis Crick Institute) which is a Centre of Excellence in Biotherapeutics. BCI is committed in supporting and developing future cancer researchers through its extensive postgraduate training.
About Queen Mary
At Queen Mary University of London, we believe that a diversity of ideas helps us achieve the previously unthinkable.
Throughout our history, we’ve fostered social justice and improved lives through academic excellence. And we continue to live and breathe this spirit today, not because it’s simply ‘the right thing to do’ but for what it helps us achieve and the intellectual brilliance it delivers.
We continue to embrace diversity of thought and opinion in everything we do, in the belief that when views collide, disciplines interact, and perspectives intersect, truly original thought takes form.
We offer competitive salaries, access to a generous pension scheme, 30 days’ leave per annum (pro-rata for part-time/fixed-term), a season ticket loan scheme and access to a comprehensive range of personal and professional development opportunities. In addition, we offer a range of work life balance and family friendly, inclusive employment policies, flexible working arrangements, and campus facilities including an on-site nursery at the Mile End campus.
The post is based at the Charterhouse Square Campus in London. It is a full-time, fixed-term appointment for 3 years, with an expected start date of November 2023. The starting salary will be Grade 4, in the range of £40,223- £44,722 per annum (pro-rata), inclusive of London Allowance.
Queen Mary’s commitment to our diverse and inclusive community is embedded in our appointments processes. Reasonable adjustments will be made at each stage of the recruitment process for any candidate with a disability. We are open to considering applications from candidates wishing to work flexibly.
Informal enquiries should be addressed to Andy Finch at firstname.lastname@example.org.
To apply for the role, please click the ‘Apply’ button.
The closing date for applications is 12 October 2023.
Interviews are expected to be held around 2 weeks after the closing date.
Type / Role: